Discover
TNXP
Tonix Pharmaceuticals Holding Corp.
12.44
2 x 11.51
1 x 13.00
bid
ask
-
0.32
2.51%
2 @ 04:00 PM
12.76 +0.32 (2.54%)
| Ytd | -20.36% | |
| 1y | -64.63% |
12.29
day range
12.97
10.03
52 week range
69.97
| Open | 12.84 | Prev Close | 12.76 | Low | 12.29 | High | 12.97 | Mkt Cap | 198.30M |
| Vol | 287.50K | Avg Vol | 485.44K | EPS | -14.66 | P/E | N/A | Forward P/E | -0.01 |
| Beta | 2.08 | Short Ratio | 0.35 | Inst. Own | 0.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 12.73 | 200-d Avg | 16.21 | 1yr Est | 5.83 |
| Income Statement | |||
| Total Revenue | 6.88M | ||
| Revenues (USD) | 6.88M | ||
| Cost of Revenue | 1.58M | ||
| Gross Profit | 5.30M | ||
| Operating Expenses | 46.84M | ||
| Research and Development Expense | 18.21M | ||
| Selling, General and Administrative Expense | 28.62M | ||
| Operating Income | -41.54M | ||
| Net Income | -40.19M | ||
| Net Income Common Stock | -40.19M | ||
| Net Income Common Stock (USD) | -40.19M | ||
| Consolidated Income | -40.19M | ||
| Earnings per Basic Share | -2.93 | ||
| Earnings per Basic Share (USD) | -2.93 | ||
| Earnings per Diluted Share | -2.93 | ||
| Earning Before Interest & Taxes (EBIT) | -40.19M | ||
| Earning Before Interest & Taxes (USD) | -40.19M | ||
| Weighted Average Shares | 13.71M | ||
| Weighted Average Shares Diluted | 13.71M | ||
| Balance Sheet | |||
| Cash and Equivalents | 185.47M | ||
| Cash and Equivalents (USD) | 185.47M | ||
| Trade and Non-Trade Receivables | 8.82M | ||
| Current Assets | 207.17M | ||
| Property, Plant & Equipment Net | 46.34M | ||
| Total Assets | 257.91M | ||
| Debt Current | 162.00K | ||
| Total Debt | 1.29M | ||
| Current Liabilities | 29.65M | ||
| Debt Non-Current | 1.13M | ||
| Total Liabilities | 30.78M | ||
| Accumulated Retained Earnings (Deficit) | -894.91M | ||
| Accumulated Other Comprehensive Income | -283.00K | ||
| Shareholders Equity | 227.14M | ||
| Shareholders Equity (USD) | 227.14M | ||
| Assets Non-Current | 50.74M | ||
| Total Debt (USD) | 1.29M | ||
| Goodwill and Intangible Assets | 120.00K | ||
| Inventory | 3.65M | ||
| Liabilities Non-Current | 1.13M | ||
| Trade and Non-Trade Payables | 9.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 555.00K | ||
| Net Cash Flow from Financing | 20.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -23.80M | ||
| Capital Expenditure | -1.69M | ||
| Issuance (Purchase) of Equity Shares | 20.20M | ||
| Net Cash Flow from Investing | -1.69M | ||
| Net Cash Flow from Operations | -42.32M | ||
| Effect of Exchange Rate Changes on Cash | 6.00K | ||
| Share Based Compensation | 1.97M | ||